NVCR vs TFC · rev $357.6M vs rev $11.82B
Novocure Ltd (NVCR) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Novocure Ltd (NVCR) is a medical devices company listed on US.
TFC (TFC) common stock.
Latest reported NVCR revenue for 2026-06-30 was $357.6M. Net income was -$86.8M. NVCR currently screens at market cap $1.99B.
Latest reported TFC revenue for 2026-06-30 was $11.82B. Net income was $3.03B. TFC currently screens at market cap $0.
NVCR currently screens at market cap $1.99B. TFC currently screens at market cap $0.
Not investment advice. Open the NVCR and TFC stock pages for the full models.
Not investment advice.